The client’s wearable technology, a non-drug, pain management system, is designed to relieve symptoms of Painful Peripheral Diabetic Neuropathy (PPDN) using electromagnetic energy.
In order to fully assess and execute a market access strategy for their product launch, our client needed to (1) develop a full understanding of the current standard of care (SOC) with respect to resource consumption and costs associated with PPDN, and (2) understand reimbursement options for their product.
We conducted a reimbursement assessment to define the appropriate patient population and usage scenarios for the client’s technology based on consideration of the current and evolving payer environment. Both traditional payer reimbursement (fee-for-service) and value-based reimbursement systems were reviewed as options for the client’s technology. We also conducted a health economic assessment and evaluation.